Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Operating Leases: 2022

Historic Operating Leases for Cullinan Therapeutics (CGEM) over the last 1 years, with Dec 2022 value amounting to $3.6 million.

  • Cullinan Therapeutics' Operating Leases fell 38.73% to $2.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.4 million, marking a year-over-year decrease of 38.73%. This contributed to the annual value of $3.6 million for FY2022, which is N/A change from last year.
  • Per Cullinan Therapeutics' latest filing, its Operating Leases stood at $3.6 million for FY2022.
  • In the past 5 years, Cullinan Therapeutics' Operating Leases registered a high of $3.6 million during FY2022, and its lowest value of $3.6 million during FY2022.
  • Over the past 1 years, Cullinan Therapeutics' median Operating Leases value was $3.6 million (recorded in 2022), while the average stood at $3.6 million.